Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulation

Sara Bahattab(King Saud bin Abdulaziz University for Health Sciences), Sabine Matou‐Nasri(King Abdullah International Medical Research Center)
Saudi Pharmaceutical Journal
March 30, 2024
Cited by 3


Related Papers